• Login
    View Item 
    •   Home
    • Research Publications
    • Research Centres & Groups
    • Human Sciences Research Centre
    • View Item
    •   Home
    • Research Publications
    • Research Centres & Groups
    • Human Sciences Research Centre
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of UDORACommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    About and further information

    AboutOpen Access WebpagesOpen Access PolicyTake Down Policy University Privacy NoticeUniversity NewsTools for ResearchersLibraryUDo

    Statistics

    Display statistics

    Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Publisher version
    View Source
    Access full-text PDFOpen Access
    View Source
    Check access options
    Check access options
    Authors
    O'Harte, Finbarr P M
    Parthsarathy, Vadivel
    Hogg, Christopher
    Flatt, Peter R
    Affiliation
    University of Ulster
    Issue Date
    2017-10-04
    
    Metadata
    Show full item record
    Abstract
    The adipokine, apelin has many biological functions but its activity is curtailed by rapid plasma degradation. Fatty acid derived apelin analogues represent a new and exciting avenue for the treatment of obesity-diabetes. This study explores four novel fatty acid modified apelin-13 analogues, namely, Lys8GluPAL)apelin-13 amide, pGlu(Lys8GluPAL)apelin-13 amide, Lys8GluPAL(Tyr13)apelin-13 and Lys8GluPAL(Val13)apelin-13. Fatty acid modification extended the half-life of native apelin-13 to >24 h in vitro. pGlu(Lys8GluPAL)apelin-13 amide was the most potent insulinotropic analogue in BRIN-BD11 cells and isolated islets with maximal stimulatory effects of up to 2.7-fold (p < .001). (Lys8GluPAL)apelin-13 amide (1.9-fold) and Lys8GluPAL(Tyr13)apelin-13 (1.7-fold) were less effective, whereas Lys8GluPAL(Val13)apelin-13 had an inhibitory effect on insulin secretion. Similarly, pGlu(Lys8GluPAL)apelin-13 amide was most potent in increasing beta-cell intracellular Ca2+ concentrations (1.8-fold, p < .001) and increasing glucose uptake in 3T3-L1 adipocytes (2.3-fold, p < .01). Persistent biological action was observed with both pGlu(Lys8GluPAL)apelin-13 amide and (Lys8GluPAL)apelin-13 amide significantly reducing blood glucose (39-43%, p < .01) and enhancing insulin secretion (43-56%, p < .001) during glucose tolerance tests in diet-induced obese mice. pGlu(Lys8GluPAL)apelin-13 amide and (Lys8GluPAL)apelin-13 amide also inhibited feeding (28-40%, p < .001), whereas Lys8GluPAL(Val13)apelin-13 increased food intake (8%, p < .05) in mice. These data indicate that novel enzymatically stable analogues of apelin-13 may be suitable for future development as therapeutic agents for obesity-diabetes.
    Citation
    O'Harte, F., Parthsarathy, V., Hogg, C., and Flatt, P. (2017). 'Acylated apelin-13 amide analogues exhibit enzyme resistance and prolonged insulin releasing, glucose lowering and anorexic properties'. Biochemical Pharmacology, 146 . pp. 165-173.
    Publisher
    Elsevier
    Journal
    Biochemical pharmacology
    URI
    http://hdl.handle.net/10545/624634
    DOI
    10.1016/j.bcp.2017.10.002
    PubMed ID
    28987595
    Additional Links
    http://uir.ulster.ac.uk/38767/
    https://www.sciencedirect.com/science/article/abs/pii/S0006295217306160?via%3Dihub
    Type
    Article
    Language
    en
    EISSN
    1873-2968
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.bcp.2017.10.002
    Scopus Count
    Collections
    Human Sciences Research Centre

    entitlement

    Related articles

    • Apelin-13 analogues show potent in vitro and in vivo insulinotropic and glucose lowering actions.
    • Authors: O'Harte FPM, Parthsarathy V, Hogg C, Flatt PR
    • Issue date: 2018 Feb
    • Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice.
    • Authors: O'Harte FPM, Parthsarathy V, Hogg C, Flatt PR
    • Issue date: 2018
    • Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    • Authors: Parthsarathy V, Hogg C, Flatt PR, O'Harte FPM
    • Issue date: 2018 Feb
    • Chronic apelin analogue administration is more effective than established incretin therapies for alleviating metabolic dysfunction in diabetic db/db mice.
    • Authors: O'Harte FPM, Parthsarathy V, Flatt PR
    • Issue date: 2020 Mar 15
    • Comparison of stability, cellular, glucose-lowering and appetite supressing effects of oxyntomodulin analogues modified at the N-terminus.
    • Authors: Lynch AM, Pathak N, Flatt YE, Gault VA, O'Harte FP, Irwin N, Flatt PR
    • Issue date: 2014 Nov 15
    DSpace software (copyright © 2002 - 2021)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.